Brief: Lipigon Pharmaceuticals Jul-Sep Operating Loss SEK 6.7 Mln
21/11/2024 10:10
Nov 21 (Reuters) - Lipigon Pharmaceuticals AB LPGO.ST :
* JUL-SEP NET REVENUE SEK 0
* JUL-SEP OPERATING LOSS SEK 6.7 MILLION
Source text: ID:nBQN6nY3Vw
Further company coverage: LPGO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Lipigon Pharmaceuticals AB
See all newsBrief: Nasdaq To Delist Lipigon Pharmaceuticals From First North Growth Market
Brief: Lipigon Expected To Be Removed From Trading On Nasdaq Stockholm On May 18
Brief: Lipigon Proposes To Delist Company From Nasdaq First NGM
Brief: Lipigon Pharmaceuticals Oct-Dec Oper Loss At SEK 7.2 Mln
Brief: Lipigon Pharmaceuticals Aims To Reduce Cost Base By Two-Thirds